NSE BSE
krebs biochemicals & ind stock

KREBS BIOCHEMICALS & IND Share Price

- - (%)
Sector: -

1937

524518

KREBSBIO

img img img img
No Data Available

KREBS BIOCHEMICALS & IND Share Price Update


As of the latest trading session, KREBS BIOCHEMICALS & IND share price is currently at 68.5, which is up by 1.44 from its previous closing. Today, the stock has fluctuated between 67.00 and 68.50. Over the past year, KREBS BIOCHEMICALS & IND has achieved a return of 0.07 %. In the last month alone, the return has been -8.58 %.

KREBS BIOCHEMICALS & IND Performance

Day Range

Low67.00 High68.50
68.20

52 Week Range

Low 59.20 High 93.95
68.20

Open Price

67.00

Prev. Close

67.05

Volume (Shares)

1382.00

Total traded value

.94

Upper Circuit

70.40

Lower Circuit

63.70

Note: The current prices & values are delayed, Login to your account for live updates.

KREBS BIOCHEMICALS & IND Fundamentals


(Standalone)

Market Cap (Cr) 147.00
PE Ratio (TTM) 0.00
Book Value / Share -50.26
Beta 0.57
ROE 0.00%
EPS (TTM) 0.00
Dividend Yield 0.00%
Net Profit Qtr (Cr) -4.98

KREBS BIOCHEMICALS & IND Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars DEC 2023 (Values in Cr)
Revenue 12.98
Operating Expense 17.99
Net Profit -4.98
Net Profit Margin (%) -38.36
Earnings Per Share (EPS) -2.31
EBITDA -2.06
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 14.89
Operating Expense 18.63
Net Profit -3.57
Net Profit Margin (%) -23.97
Earnings Per Share (EPS) -1.66
EBITDA -0.73
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 10.58
Operating Expense 15.95
Net Profit -5.33
Net Profit Margin (%) -50.37
Earnings Per Share (EPS) -2.47
EBITDA -2.58
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 11.46
Operating Expense 18.60
Net Profit -6.94
Net Profit Margin (%) -60.55
Earnings Per Share (EPS) -3.07
EBITDA -4.43
Effective Tax Rate (%) 0.00
Particulars DEC 2022 (Values in Cr)
Revenue 9.09
Operating Expense 14.67
Net Profit -5.55
Net Profit Margin (%) -61.05
Earnings Per Share (EPS) -2.58
EBITDA -2.95
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 52.13
Operating Expense 77.44
Net Profit -24.69
Net Profit Margin (%) -47.36
Earnings Per Share (EPS) -11.30
EBITDA -15.16
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 59.70
Operating Expense 105.38
Net Profit -44.53
Net Profit Margin (%) -74.58
Earnings Per Share (EPS) -20.81
EBITDA -32.84
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 38.61
Operating Expense 82.68
Net Profit -28.36
Net Profit Margin (%) -73.45
Earnings Per Share (EPS) -14.37
EBITDA -16.95
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 23.58
Operating Expense 62.65
Net Profit -28.87
Net Profit Margin (%) -122.43
Earnings Per Share (EPS) -17.90
EBITDA -18.26
Effective Tax Rate (%) 0.00
Particulars MAR 2019 (Values in Cr)
Revenue 37.13
Operating Expense 68.21
Net Profit -20.01
Net Profit Margin (%) -53.89
Earnings Per Share (EPS) -12.83
EBITDA -9.37
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share -46.13
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.78
EBITDA Margin -29.08
Particulars MAR 2022 (Values in Cr)
Book Value / Share -34.83
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 2.23
EBITDA Margin -55.01
Particulars MAR 2021 (Values in Cr)
Book Value / Share -23.91
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -31.56
Particulars MAR 2020 (Values in Cr)
Book Value / Share -13.89
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -54.44
Particulars MAR 2019 (Values in Cr)
Book Value / Share -8.59
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -19.51
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.08
Total Assets 174.98
Total Liabilities 174.98
Total Equity -99.46
Share Outstanding 21560000
Price to Book Ratio -1.22
Return on Assets (%) -14.11
Return on Capital (%) -29.47
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 189.80
Total Liabilities 189.80
Total Equity -75.09
Share Outstanding 21560000
Price to Book Ratio -4.12
Return on Assets (%) -23.45
Return on Capital (%) -65.65
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.71
Total Assets 159.22
Total Liabilities 159.22
Total Equity -42.73
Share Outstanding 19620000
Price to Book Ratio -3.72
Return on Assets (%) -17.81
Return on Capital (%) -41.82
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.17
Total Assets 133.80
Total Liabilities 133.80
Total Equity -24.99
Share Outstanding 18000000
Price to Book Ratio -5.90
Return on Assets (%) -21.57
Return on Capital (%) -71.27
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 17.31
Total Assets 142.36
Total Liabilities 142.36
Total Equity -14.28
Share Outstanding 16630000
Price to Book Ratio -13.50
Return on Assets (%) -14.05
Return on Capital (%) -55.68
Particulars MAR 2023 (Values in Cr)
Net Income -24.69
Cash from Operations -24.71
Cash from Investing -12.64
Cash from Financing 37.34
Net change in Cash -0.01
Free Cash Flow -9.55
Particulars MAR 2022 (Values in Cr)
Net Income -44.52
Cash from Operations -17.21
Cash from Investing -22.89
Cash from Financing 39.50
Net change in Cash -0.61
Free Cash Flow 9.86
Particulars MAR 2021 (Values in Cr)
Net Income -28.35
Cash from Operations -14.57
Cash from Investing -22.54
Cash from Financing 37.66
Net change in Cash 0.53
Free Cash Flow 3.18
Particulars MAR 2020 (Values in Cr)
Net Income -28.87
Cash from Operations -35.49
Cash from Investing -10.22
Cash from Financing 28.57
Net change in Cash -17.14
Free Cash Flow -26.79
Particulars MAR 2019 (Values in Cr)
Net Income -20.12
Cash from Operations 3.89
Cash from Investing -4.31
Cash from Financing 17.32
Net change in Cash 16.90
Free Cash Flow 8.23
Company Name Price P/E P/B Market Cap 52 Week Low/High
BLISS GVS PHARMA LTD 109.55 11.97 1.18 1146.89 71.00 / 148.95
CIPLA LTD 1399.35 26.53 4.23 112982.81 911.80 / 1519.00
FERMENTA BIOTECH LIMITED 161.20 0.00 1.65 474.43 132.30 / 214.00
GLAXOSMITHKLINE PHARMA LT 2291.55 56.12 21.83 38820.24 1265.00 / 2649.95
SANOFI INDIA LIMITED 8857.55 35.96 20.09 20398.94 6253.40 / 9370.35
Company Name Price P/E P/B Market Cap 52 Week Low/High
KREBS BIOCHEMICALS & IND 67.00 0.00 -1.33 144.46 59.30 / 93.20
AMRUTAJAN HEALTH LTD 743.50 48.85 8.20 2149.51 556.05 / 802.60
ASTRAZENECA PHARMA IND LT 5757.75 90.25 21.97 14394.38 3131.10 / 7208.00
BLISS GVS PHARMA LTD 109.55 15.13 1.16 1146.89 71.00 / 148.95
ABBOTT INDIA LIMITED 26490.20 46.86 15.21 56291.68 20594.25 / 29628.15

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 66.90
  • 26 Days 69.90
  • 10 Days 68.50
  • 50 Days 69.80
  • 12 Days 68.60
  • 100 Days 71.40
  • 20 Days 69.80
  • 200 Days 68.60
66.92
PIVOT
First Resistance 68.13
Second Resistance 69.22
Third Resistance 70.43
First Support 65.83
Second Support 64.62
Third Support 63.53
RSI 35.16
MACD -1.33
Commodity Channel Index (CCI) -117.90
ADX 18.60
Williams % R -66.67

Over 1 Month

down

-8.58

Over 3 Months

down

-9.87

Over 6 Months

down

-16.60

Over 1 Year

down

0.07

Over 3 Years

down

-17.61

Over 5 Years

down

-6.67

KREBS BIOCHEMICALS & IND Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

KREBS BIOCHEMICALS & IND Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
26.75
Promoter Holdings
72.74
FII
0.49
DII
0.0
Promoter Shares(Pledge Percentage)
0.0
Name Category Shares Shares%
Ipca Laboratories Limited Shareholding of Promoter and Promoter Group 1.0705195E7 49.65
Hemalatha Ravi Shareholding of Promoter and Promoter Group 2691524.0 12.48
Avinash Ravi Shareholding of Promoter and Promoter Group 2140272.0 9.93
Sun Pharmaceutical Industries Ltd Public Shareholding 1036943.0 4.81
Ajay Ravi Shareholding of Promoter and Promoter Group 112997.0 0.52
Dr R T Ravi Shareholding of Promoter and Promoter Group 23474.0 0.11
Aditya Ravi Shareholding of Promoter and Promoter Group 10672.0 0.05

KREBS BIOCHEMICALS & IND

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About KREBS BIOCHEMICALS & IND

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by KREBS BIOCHEMICALS & IND

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Krebs Biochemicals & Industries Ltd?

Answer Field

The share price of Krebs Biochemicals & Industries Ltd for NSE is ₹ 68.5 and for BSE is ₹ 0.

What is the Market Cap of Krebs Biochemicals & Industries Ltd?

Answer Field

The market cap of Krebs Biochemicals & Industries Ltd for NSE is ₹ 147.00 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Krebs Biochemicals & Industries Ltd?

Answer Field

The 52 Week High and Low of Krebs Biochemicals & Industries Ltd for NSE is ₹ 93.95 and ₹ 59.20 and for BSE is ₹ 93.20 and ₹ 59.30.

How to Buy Krebs Biochemicals & Industries Ltd share?

Answer Field

You can trade in Krebs Biochemicals & Industries Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Krebs Biochemicals & Industries Ltd?

Answer Field

The 1 year returns on the stock has been 0.07%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7 Lac+ Users

icon-with-text

4.3 App Rating

icon-with-text

4 Languages

icon-with-text

₹ 3800 Cr MTF Book

icon-with-text
loader